{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:52Z","timestamp":1759333672933},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf00050913","type":"journal-article","created":{"date-parts":[[2007,2,4]],"date-time":"2007-02-04T01:28:46Z","timestamp":1170552526000},"page":"25-27","source":"Crossref","is-referenced-by-count":21,"title":["Drugs affecting plasma fibrinogen levels"],"prefix":"10.1007","volume":"6","author":[{"given":"Giovanni","family":"di Minno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00050913_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.10.1.1","volume":"10","author":"G Minno Di","year":"1990","unstructured":"Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990;10:1\u20137.","journal-title":"Arteriosclerosis"},{"key":"BF00050913_CR2","volume-title":"Thrombosis and haemostasis 1987","author":"GR Crabtree","year":"1987","unstructured":"Crabtree GR, Courtois G, Morgan JG. Cellular and nuclear factors coordinating the expression of the three fibrinogen genes. In: Verstraete M, Vermylen J, Lijenen HR, and Arnout J, eds. Thrombosis and haemostasis 1987. Leuven: International Society on Thrombosis and Haemostasis and Leuven University Press, 1987."},{"key":"BF00050913_CR3","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1016\/S0021-9258(17)43926-3","volume":"258","author":"S Yu","year":"1983","unstructured":"Yu S, Sher B, Kudryk B, Redman CM. Intracellular assembly of human fibrinogen. J Biol Chem 1983;258:13407\u201313410.","journal-title":"J Biol Chem"},{"key":"BF00050913_CR4","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1016\/S0021-9258(18)91001-X","volume":"259","author":"S Yu","year":"1984","unstructured":"Yu S, Sher B, Kudryk B, Redman CM. Intracellular assembly of human fibrinogen. J Biol Chem 1984;259:10574\u201310581.","journal-title":"J Biol Chem"},{"key":"BF00050913_CR5","first-page":"588","volume":"61","author":"J Le","year":"1989","unstructured":"Le J, Vilcek J. Interleukin-6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61:588\u2013602.","journal-title":"Lab Invest"},{"key":"BF00050913_CR6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T. Interleukin 6 and the acute phase response. Biochem J 1990;265:621\u2013636.","journal-title":"Biochem J"},{"key":"BF00050913_CR7","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.1016\/S0021-9258(18)61042-7","volume":"262","author":"E Evans","year":"1987","unstructured":"Evans E, Courtois GM, Kilian P, et al. Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters. J Biol Chem 1987;262:10850\u201310854.","journal-title":"J Biol Chem"},{"key":"BF00050913_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.297.6642.180","volume":"297","author":"AT Hostmark","year":"1988","unstructured":"Hostmark AT, Bjerkedal T, Kierulf P, et al. Fish oil and plasma fibrinogen. Br Med J 1988;297:180\u2013181.","journal-title":"Br Med J"},{"key":"BF00050913_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-111-9-757","volume":"11","author":"K Radack","year":"1989","unstructured":"Radack K, Deck C, Huster G. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: A randomized, double-blind controlled study. Ann Intern Med 1989;11: 757\u2013758.","journal-title":"Ann Intern Med"},{"key":"BF00050913_CR10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","volume":"2","author":"ML Burr","year":"1989","unstructured":"Burr ML, Fehiky AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction: Diet and reinfarction trial (DART). Lancet 1989;2:757\u2013761.","journal-title":"Lancet"},{"key":"BF00050913_CR11","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.4049\/jimmunol.139.12.4186","volume":"139","author":"RJ Sperling","year":"1987","unstructured":"Sperling RJ, Robin JL, Kylander KA, et al. The effects of n-3 polyunsaturated fatty acids on the generation of platelet activating factor-acether by human monocytes. J Immunol 1987;139:4186\u20134191.","journal-title":"J Immunol"},{"key":"BF00050913_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","volume":"320","author":"S Endres","year":"1989","unstructured":"Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265\u2013271.","journal-title":"N Engl J Med"},{"key":"BF00050913_CR13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(87)92556-6","volume":"2","author":"TW Meade","year":"1987","unstructured":"Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;2:986\u2013989.","journal-title":"Lancet"},{"key":"BF00050913_CR14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(87)92557-8","volume":"1","author":"A Hamsten","year":"1987","unstructured":"Hamsten A, Iselius L, De Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987;1:988\u2013990.","journal-title":"Lancet"},{"key":"BF00050913_CR15","first-page":"405","volume":"65","author":"O Bagasra","year":"1988","unstructured":"Bagasra O, Howeedy A, Kajdacsy-Balla A. Macrophage function in chronic experimental alcoholism. Modulation of surface receptors and phagocytosis. Immunology 1988;65: 405\u2013409.","journal-title":"Immunology"},{"key":"BF00050913_CR16","first-page":"84","volume":"114","author":"F Balsano","year":"1989","unstructured":"Balsano F, Coccheri S, Libretti A, et al. Ticlopidine in the treatment of intermittent claudication: A 21-month doubleblind trial. J Lab Clin Med 1989;114:84\u201391.","journal-title":"J Lab Clin Med"},{"key":"BF00050913_CR17","unstructured":"Takamatsu S, Sato K, Takamatsu M, et al. A two year follow up study on blood constituents in aged arteriosclerotic patients treated with pentoxifylline. Proceedings of the 28th International Congress of Physiological Sciences, Tubingen, West Germany, 1980."},{"key":"BF00050913_CR18","first-page":"150","volume":"1","author":"B Angelkort","year":"1983","unstructured":"Angelkort B, Pirnay D, Kieswater H, Maurin N. Hemodilution and pentoxifylline effects on muscle blood flow and blood fluidity in chronic arterial occlusive disease. Vasc Med 1983;1:150\u2013158.","journal-title":"Vasc Med"},{"issue":"Suppl 1","key":"BF00050913_CR19","first-page":"74","volume":"3","author":"M Muggeo","year":"1983","unstructured":"Muggeo M, Calabro A, Businaro V, et al. Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: The effects of pentoxifylline in the treatment of acute vascular disease. Pharmacotherapeutica 1983;3(Suppl 1):74\u201390.","journal-title":"Pharmacotherapeutica"},{"issue":"Suppl 1","key":"BF00050913_CR20","first-page":"105","volume":"22","author":"E Ott","year":"1983","unstructured":"Ott E, Fazekas F, Lechner H. Haemorheological effects of pentoxifylline in disturbed blood flow behaviour in patients with cerebrovascular disease. Neurology 1983;22(Suppl 1): 105\u2013107.","journal-title":"Neurology"},{"key":"BF00050913_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/000331978403500705","volume":"35","author":"T Perri Di","year":"1984","unstructured":"Di Perri T, Carandente O, Vittoria O, et al. Studies on the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease. Angiology 1984;35:427\u2013435.","journal-title":"Angiology"},{"key":"BF00050913_CR22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/000331978403500709","volume":"35","author":"A Strano","year":"1984","unstructured":"Strano A, Davi' G, Avellone G, et al. Double-blind crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 1984;35:439\u2013446.","journal-title":"Angiology"},{"key":"BF00050913_CR23","doi-asserted-by":"crossref","first-page":"13199","DOI":"10.1016\/S0021-9258(18)90677-0","volume":"259","author":"SP Watson","year":"1984","unstructured":"Watson SP, McConnel RT, Lapetina EG. The formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem 1984;259:13199\u201313203.","journal-title":"J Biol Chem"},{"key":"BF00050913_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0038-1645040","volume":"63","author":"P Andersen","year":"1990","unstructured":"Andersen P, Smith P, Seljeflot I, et al. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction. Thromb Haemost 1990;63:174\u2013177.","journal-title":"Thromb Haemost"},{"key":"BF00050913_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0021-9150(88)90135-9","volume":"71","author":"G Niort","year":"1988","unstructured":"Niort G, Bulgarelli A, Cassader M, Pagano G. Effect of short term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients. Atherosclerosis 1988;71:113\u2013119.","journal-title":"Atherosclerosis"},{"key":"BF00050913_CR26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/978-3-642-71702-4_69","volume-title":"Drugs affecting lipid metabolism","author":"G Ciuffetti","year":"1987","unstructured":"Ciuffetti G, Orecchini G, Siepi D, et al. Hemorheological activity of gemfibrozil in primary hyperlipidemias. In: Paoletti R, et al., eds. Drugs affecting lipid metabolism. Berlin: Springer-Verlag, 1987:372\u2013375."},{"key":"BF00050913_CR27","first-page":"1","volume":"126","author":"G Endemann","year":"1987","unstructured":"Endemann G, Pronzcuk A, Friedman G, et al. Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Path 1987;126:1\u20136.","journal-title":"Am J Path"},{"key":"BF00050913_CR28","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1073\/pnas.86.21.8202","volume":"86","author":"V Poli","year":"1989","unstructured":"Poli V, Cortese R. Interleukin-6 induces a liver-specific nucler protein that binds to the promoter of acute-phase genes. Proc Natl Acad Sci USA 1989;86:8202\u20138206.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF00050913_CR29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0092-8674(90)90459-R","volume":"63","author":"V Poli","year":"1990","unstructured":"Poli V, Mancini FP, Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C\/EBO. Cell 1990;63:643\u2013653.","journal-title":"Cell"},{"key":"BF00050913_CR30","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(87)92205-7","volume":"1","author":"SE Humphries","year":"1987","unstructured":"Humphries SE, Cook M, Dubowitz M, et al. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987;1:1452\u20131455.","journal-title":"Lancet"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00050913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00050913\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00050913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:33:05Z","timestamp":1683736385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00050913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF00050913"],"URL":"https:\/\/doi.org\/10.1007\/bf00050913","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}